MDR-TB Clinical Trials Capacity Building
TREAT TB aims to generate high-quality evidence to guide important public health decisions. However, knowledge generation is not enough; TREAT TB aims to build the institutions required to ensure the impact of research is sustainable. By investing in capacity building through webinars and symposia; training the researchers of the future, providing training in operational research; and offering technical assistance TREAT TB seeks to strengthen public health systems around the world.
With the arrival of new therapeutic agents for tuberculosis (TB), there is an urgent need for evidence regarding optimal treatment regimens, especially for drug-resistant TB. It is therefore critical to develop research infrastructure for clinical trials in high burden settings in order to generate reliable data to inform policy and drive decisions on how to improve treatment for multidrug-resistant TB (MDR-TB). However, implementation of clinical trials on drug-resistant TB is challenging and there is a need to build capacity and increase coordination among global stakeholders to improve the existing approach to clinical trial implementation in the field.
In 2018, TREAT TB launched its capacity building webinar series which explores key implementation challenges related to clinical trials. Building on the experience of the STREAM clinical trial, the Research Division hosts regular webinars to strengthen capacity to conduct high quality trials on multidrug-resistant tuberculosis. Three webinars to date have brought together speakers from around the world to cover key topics, including supply chain management and community engagement.
To listen to the latest webinar, please click here.
To read more about the TREAT TB project, click here.
Please visit the page regularly for information on future webinars in the capacity building series and to access recordings from past webinars.